Recombinant rodent gamma interferon (IFN-y) clonally isolated from cultures treated with IFN-,y was resistant to IFN--y-mediated inhibition, but four serial passages of these resistant clones in the absence of additional IFN--y resulted in the loss of resistance. In several respects, therefore, the IFN-y-mediated inhibition of scrub typhus rickettsiae in cultured fibroblasts was similar to that reported for Rickettsia prowazekii.
IFN-y-treated cells, rickettsial replication appeared to persist at normal levels. A fraction (28%) of rickettsiae clonally isolated from cultures treated with IFN-,y was resistant to IFN--y-mediated inhibition, but four serial passages of these resistant clones in the absence of additional IFN--y resulted in the loss of resistance. In several respects, therefore, the IFN-y-mediated inhibition of scrub typhus rickettsiae in cultured fibroblasts was similar to that reported for Rickettsia prowazekii.
Rickettsia tsutsugamushi, the causative agent of scrub typhus, is a small, obligately intracellular bacterium which replicates within the cytoplasm of eukaryotic cells. In tissue culture, a wide variety of cells can support rickettsial growth, while in natural infections of animals, the cells most prominently parasitized are vascular endothelial cells. Nonfatal rickettsial infections of humans are generally considered to be acute, self-limiting diseases, but much evidence points to the persistence of rickettsiae in infected hosts long after clinical recovery. Rickettsiae are maintained in nature in a variety of mammals and are transmitted by arthropod vectors. In all of these properties, R. tsutsugamushi is like other members of the genus Rickettsia. In contrast, scrub typhus rickettsiae have several characteristics which distinguish them from other Rickettsia species: cell wall ultrastructure (29) and chemical composition (1) , staining properties, resistance to such antibiotics as penicillin and streptomycin, lack of T-cell-independent antibody induction (8, 13) , and certain growth requirements (17) . Thus, although definite similarities exist among all the rickettsiae, free extrapolation from R. tsutsugamushi to other Rickettsia species is unwarranted.
Rickettsiae of several species have been shown to induce interferons (IFNs). Rickettsia prowazekii and Rickettsia typhii, both in the typhus group, induced acid-stable, IFNlike viral inhibitors in mice (11) and in cultured chicken embryo cells (16) , respectively. More recently, infection of cultured mouse fibroblast cells with R. prowazekii was found to stimulate the production of IFN-a/,p (38, 39) . In R.
tsutsugamushi-infected primary chicken embryo cell cultures, the appearance of an acid-stable, virus-inhibitory protein followed increases in infectious rickettsiae (7) . In addition, T-cell lines specific for scrub typhus rickettsial antigen which secrete IFN-,y upon stimulation have been established (6, 14) . In vivo, primary infection of cynomolgus monkeys with R. tsutsugamushi resulted in the appearance of IFN--y in plasma 2 weeks later (19) , and the peritoneal cells of mice first contained detectable IFN-y mRNA 5 to 7 days after intraperitoneal inoculation of R. tsutsugamushi (27) . Mice immune to R. tsutsugamushi are capable of rapid IFN--y production upon challenge with scrub typhus rickettsial antigen, with peak titers in serum occurring as soon as 4 h after antigenic stimulation (9, 26) .
The contribution of IFN to recovery from acute infection or to prevention of recrudescence of persisting rickettsiae is not entirely clear, but several studies have pointed to its potential importance. In studies of rickettsiae of the spotted fever group, Nacy and Meltzer (24) correlated the genetically determined resistance of certain mouse strains to lethal infection by Rickettsia akari (spotted fever group) with the capacity of their macrophages to develop rickettsicidal capacity after stimulation by lymphokines; lymphokine treatment also resulted in decreased initial entry of rickettsiae into macrophages cultured from resistant mice. Modulation by IFN-y of infection of mice with Rickettsia conorii, another spotted fever rickettsia, was suggested by the finding that treatment of the mice with monoclonal antibodies to IFN--y prevented lethal infection (18) . Mouse lymphokines containing IFN--y inhibited R. conorii growth in L929 cells (32) , and such inhibition was neutralized by anti-IFN-y monoclonal antibody (10) . However, in another study, IFN-y treatment of HEp-2 cells was reported not to inhibit replication of R. conorii, although it did enhance the inhibitory effect of tumor necrosis factor alpha (20) . Earlier work had shown that R. akari yields were inhibited by pretreatment of L cells with virus-induced IFN (12) .
The role of IFN in R. prowazekii infections of cultured macrophages, fibroblasts, and endothelial cells has been studied fairly extensively. Treatment (34, 36) . (ii) Recombinant IFN-y prevented rickettsial replication and led to the clearance of intracellular rickettsiae (31) (32) (33) 40) . (iii) IFN--y treatment resulted in the specific lysis of infected cells (30, 33, 40) . In addition, R. prowazekii has been shown recently to be inhibited by either endogenous or added IFN-a/,B (38, 39) . The mechanism by which IFN inhibits rickettsial growth is not known, but the IFN--y mediated inhibition of R. prowazekii apparently is neither due to tryptophan (or other amino acid) degradation (35) nor to induction of a respiratory burst in macrophagelike cells (30) . Alternatively, to quantitate infectious rickettsiae, irradiated cells infected in suspension as described above and thoroughly washed were distributed to 2-cm2 wells in 24-well plates at a concentration of 105 cells per ml of TCM per well.
These infected cultures also were held in the 37°C CO2 incubator. At intervals, cells were scraped from the wells directly into the TCM, briefly sonicated under conditions which disrupted the cells without killing rickettsiae, and plaqued immediately. Duplicate wells were handled separately at each stage.
Plaque assays and rickettsial cloning. The microplaque assay for infectious rickettsiae in 2-day-old BALB/3T3 monolayer cultures in 2-cm2 wells in 24-well plates has been described for a different cell line (4) . In contrast to the original method, the use of BALB/3T3 cells required that they be irradiated before infection; otherwise, no plaques were detected. The only other deviation from the published technique was the replacement of 5% FBS in the overlaying medium with 2% CPSR-4, the concentration determined to be as efficient as 5% FBS (2) . Inclusion of 5% chicken serum in the overlay medium containing CPSR-4 was required for optimum plaque formation by R. tsutsugamushi, just as it was needed in the FBS-containing overlay medium (2, 4) .
Rickettsial clones were obtained by a combination of endpoint dilution and plaquing. Wells containing only one rickettsial plaque were identified microscopically without prior staining; the agarose from these wells was removed, and the cells were scraped into BAP, centrifuged, resuspended in BAP, and disrupted by sonication. The released rickettsiae were either immediately replaqued or stored frozen at -70°C. On average, about 104 PFU were recovered from a single plaque after incubation for 2 weeks.
IFN. Recombinant rat IFN--y (107 IU/mg of protein) was purchased from Amgen Biologicals (Thousand Oaks, Calif.), studies, unless otherwise noted, 1-day-old, just confluent monolayer cultures (which were in flasks when cells were to be infected in suspension or in 24-well plates for the plaque assay) were treated with IFN--y approximately 18 h before infection by replacing the medium with TCM containing the appropriate concentration of IFN--y. Controls were treated identically, except that the replacement medium contained no IFN--y.
RESULTS
Effect of IFN-y on R. tsutsugamushi replication. R. tsutsugamushi replication in BALB/3T3 cells was examined after a variety of IFN--y treatments. Confluent monolayers of uninfected cells grown in 2-cm2 wells were treated overnight with 500 IU of IFN--y per ml of TCM or with TCM only. The next morning, the cells were trypsinized from the wells, washed, irradiated, and infected in suspensions containing 2 x 105 cells and 2 x 106 rickettsial PFU/ml. After 1-h incubation in suspension with rickettsiae to permit attachment and penetration of the organisms, the cells were again washed by centrifugation, suspended in TCM with or without additional IFN--y (500 IU/ml), distributed to chamber slides, and incubated at 37°C. Slides were fixed at the indicated intervals and stained with Giemsa stain to monitor rickettsial growth.
Control cultures which received no IFN-y supported rickettsial replication to a typical extent, with a rickettsial doubling time of 6.8 h between 24 and 72 h postinfection (Fig. 1A) . As (Fig. 2B) .
In contrast to these controls, IFN--y treatment of the cultures treated only once, 18 h before infection, resulted in an apparent lag period before logarithmic increase of rickettsiae began, agreeing with the results shown in Fig. 1 (Fig.  2A) . The addition of 100 IU of IFN--y per ml on a daily basis appeared to be slightly more effective than one treatment, but by no means did it completely prevent rickettsial replication. Thus, the, lag period may have been somewhat prolonged, but at 120 h postinfection, the average Rlc was reduced by 83% by daily treatment as opposed to 74% reduction by one treatment, which is not a statistically significant difference. The more-extensive treatment with IFN--y apparently did reduce spread of rickettsiae from cell to cell, with the percentage of cells infected at 120 h being 13 versus 4 after one or daily treatments, respectively (P < 0.001) (Fig. 2B) . The same general pattern of results also was obtained with less-rigorous treatments, when the IFN--y was added on alternate days (days -1, + 1, and +3 relative to the day of infection) or when only 10 IU/ml were used throughout (not shown).
The cultures treated daily had relatively few cells containing rickettsiae, but these few cells were heavily infected. This is illustrated in Fig. 3, which Relative sensitivity of Gilliam to IFN-y-mediated inhibition.
In dose-response experiments, the sensitivity of Gilliam to IFN--y closely paralleled that of the commercial (Amgen) test virus system; maximum inhibition was caused by as few as 33 antiviral IU per ml and 50% inhibition was achieved by 2 to 3 IU/ml (Fig. 4) . One standard procedure for assessing IFN--y-mediated inhibition of rickettsial replication, described above, was to count cell-associated rickettsiae (Ric) at the indicated times after infection of IFN-y-treated and control cells. Examination of other manifestations of infection in the same experiments indicated that neither simply counting the percentage of cells infected nor measuring protection of cells from rickettsia-induced cytopathology was as sensitive as counting Ric (Fig. 4) .
In a limited number of plaque reduction assays done with low concentrations of IFN--y, 50% inhibition was also achieved by about 1 Those infected cells which did attach to the chamber slide surface were spread well and grew large in size, i.e., they appeared to be healthy. This apparent cytotoxicity of IFN--y seen immediately after rickettsial infection should not be confused with the later protection from rickettsia-induced cytopathology described above.
Effect of IFN--y pretreatment on attachment and penetration of rickettsiae. BALB/3T3 cells pretreated for 18 h with IFN--y (33 to 500 IU/ml) and then irradiated were as readily invaded by R. tsutsugamushi under standard conditions of infection as were untreated controls. This was determined by comparing R/c 4 to 6 h after infection and assessing the results from several experiments by the paired t test (86.0% ± 10.5% of control, P > 0.05). Rickettsial replication, however, was inhibited in these experiments. Thus, inhibition of rickettsial growth cannot be attributed to direct prevention of rickettsial entry into cells in the cultures.
Effect of IFN-y on recovery of infectious rickettsiae early after infection. Assessment of rickettsial replication by counting stained organisms is somewhat limited because the method does not distinguish infectious rickettsiae from those which have lost their capacity to replicate but which still are recognizable microscopically. To obtain a more accurate view of the effect of IFN-y on R. tsutsugamushi and to try to distinguish inhibition of replication from rickettsial killing, the infection was monitored by scraping cells from infectedcell monolayers into TCM at intervals, disrupting both the adhered and floating cells by brief sonication, and comparing the total number of PFU in each suspension. During the first 12 h after infection, control cultures supported a nearly threefold increase in PFU recovered, while in cultures tsutsugamushi Gilliam for 1 h to permit infection, and additional aliquots were counted in the presence of trypan blue to determine the number of stain-excluding cells in each culture (Gil. 0 h). The mock-treated and IFN-y-treated, infected cells were distributed to chamber slides for incubation at 37°C; 6 and pretreated with 100 IU of IFN--y per ml, there was a twofold decrease during the same time period, resulting in a 90% reduction of infectious rickettsiae overall (Fig. 6 ). Sometime after 12 h, rickettsial replication in IFN--y-pretreated cultures appeared to recover, so that by 24 h postinfection, the infectious rickettsial yield was 42% of that from untreated wells. The initial decrease in infectious rickettsiae recovered from IFN--y-treated cells suggests that some killing occurred under conditions in which no killing was apparent in control cells.
Effect of added L-tryptophan on IFN--y-mediated inhibition.
To see whether increasing the L-tryptophan concentration of the TCM could reverse the IFN--y-mediated inhibition of Gilliam plaque formation in BALB/3T3 cells, a standard plaque reduction assay in which some of the cultures were treated with an additional 100 ,ug of L-tryptophan per ml during IFN--y pretreatment was done. IFN--y was equally effective in reducing plaque formation in the presence of the additional L-tryptophan ( (31, 32, 40) . Lysis of IFN-treated, infected cells may also contribute to decreases in overall rickettsial yield (33, 37, 40) . In both types of the experiments reported here, the rickettsiae which survived these early periods went on to replicate at normal rates.
Finally, because tryptophan degradation has been shown to be involved in the inhibitory effect of IFN--y on Toxoplasma gondii (28) , the effect of additional tryptophan in TCM on the IFN--y-mediated inhibition of R. tsutsugamushi growth was determined. Not surprisingly, since Turco and Winkler showed that IFN-y did not lead to the degradation of tryptophan in the same BALB/3T3 cell line we used (although in a different tissue culture medium) (35) , the addition of 100,ug of tryptophan per ml to the TCM did not alter the IFN--y sensitivity of Gilliam.
The earliest studies of the role of lymphokines in rickettsial infections were done by Nacy and colleagues, who described the interaction of R. tsutsugamushi Gilliam with mouse peritoneal macrophages activated either in vivo or in vitro by spleen cell-derived lymphokines (21) (22) (23) 25) . Although they did not directly look for possible effects of IFN--y, it is likely that the spleen cell lymphokines did contain IFN-y, and their results resemble those reported here for the interaction of R. tsutsugamushi Gilliam in BALB/c mouse-derived fibroblasts. Thus, they also noted a persistent fraction of replicating rickettsiae in a small proportion of the infected cells and apparent rickettsial killing in activated macrophages. In addition, these researchers found a decrease in the initial infection of the activated peritoneal macrophages after lymphokine treatment, similar to that reported for R. prowazekii entry into lymphokine-or recombinant IFN--y-treated macrophagelike cells (33) . Moreover, Kodama et al. (15) recently described the cytotoxicity of combined lymphokine treatment and scrub typhus rickettsial infection of cultured macrophages.
It is likely that more than one mechanism is involved in maintaining the delicate balance of rickettsial survival without killing their mammalian hosts and because IFN--y has many effects on various types of cells, the mechanisms by which it may inhibit rickettsiae in vivo may also be numerous. However, the present studies and some preceding ones indicate that IFN--y can provide a means of rickettsial destruction while they are sequestered in nonphagocytic cells. The undiminished replication of rickettsiae in a few cells after treatment with IFN--y (as described above; 25, 40) and the ready isolation of rickettsial clones which are resistant to this inhibition (as described above; 37-39) are interesting observations in light of the known persistence of rickettsiae in infected hosts. This escape by a few rickettsiae from IFN-,y-mediated degradation may be important in providing a means by which these microorganisms ensure their survival in their mammalian reservoirs.
The results of these experiments are not presented to serve as a model for what occurs in infected animals but rather to understand the interaction of rickettsiae and nonphagocytic target cells in the presence of IFN--y. Additional effects of IFN--y on the immune response are assumed, and different effects on infection in macrophages may also be anticipated. These studies, done with only one scrub typhus rickettsial strain and with one cell line, have been useful in showing that R. tsutsugamushi replication can be inhibited by IFN-y, in characterizing the inhibition, and in establishing methods for showing this inhibition. The existence of scrub typhus rickettsial strains with different virulence in particular mouse strains has led us to widen our examination of the sensitivity of R. tsutsugamushi to IFN, and in the following report, it will be demonstrated that the combination of Gilliam and BALB/3T3 cells is particularly sensitive to IFN-y-mediated inhibition (5) .
